Oklahoma 2024 Regular Session

Oklahoma Senate Bill SB214

Introduced
2/6/23  
Refer
2/7/23  
Report Pass
2/13/23  
Engrossed
3/13/23  
Refer
3/29/23  
Refer
4/5/23  

Caption

Oklahoma Center for the Advancement of Science and Technology; requiring certain commitments before awarding certain contracts for health research projects; providing for exception. Effective date.

Impact

The bill modifies Sections 5060.16 and 5060.17 of Title 74 of the Oklahoma Statutes, instituting stricter criteria for awarding professional service contracts. Key stipulations include a requirement that investigators be residents of Oklahoma or become residents within 90 days post-funding. Furthermore, the institutions administering contracts must be based in Oklahoma, thereby promoting state-centric research activities and potentially enhancing local economic benefits.

Summary

SB214 is a legislative bill aimed at amending existing statutes regarding the funding and administration of health research projects through the Oklahoma Center for the Advancement of Science and Technology (OCAST). Specifically, the bill seeks to ensure that funding is allocated based solely on the scientific merit of proposed projects. It outlines the center's responsibilities in managing these funds, emphasizing accountability and efficiency in health research initiatives.

Sentiment

Overall sentiment surrounding SB214 appears favorable, particularly among legislative members who advocate for strong scientific standards and local involvement in research funding. Supporters argue that the bill will improve the quality of health research funded by ensuring accountability from recipients. However, there could be concerns raised regarding the restrictions imposed on researchers and institutions, particularly those based out of state, which may see this as a barrier to collaborative efforts.

Contention

Notably, potential points of contention could arise from the mandates that prohibit contract transfers to out-of-state institutions and strictly limit fund expenditure for patient care unless intrinsic to the contract. Critics might argue that these provisions could hinder broader collaborative health initiatives that involve out-of-state researchers or institutions. The effectiveness and feasibility of tracking compliance with funding outcomes over multiple years may further fuel debate.

Companion Bills

OK SB214

Carry Over Oklahoma Center for the Advancement of Science and Technology; requiring certain commitments before awarding certain contracts for health research projects; providing for exception. Effective date.

Similar Bills

OK SB214

Oklahoma Center for the Advancement of Science and Technology; requiring certain commitments before awarding certain contracts for health research projects; providing for exception. Effective date.

RI S2396

Mandates insurance policies, provides coverage to diagnose & treat infertility for women between 25 & 42 years, including pre-implantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF).

RI S0107

Accident And Sickness Insurance Policies

RI H5351

Accident And Sickness Insurance Policies

RI H7878

Mandates insurance policies, provides coverage to diagnose & treat infertility for women between 25 & 42 years, including pre-implantation genetic diagnosis (PGD) in conjunction with in vitro fertilization (IVF).

RI H7877

Mandates all insurance contracts, plans or policies provide insurance coverage for the expense of testing and treating infertility, including preimplantation genetic testing (PGT), in conjunction with in vitro fertilization (IVF).

RI H8120

Accident And Sickness Insurance Policies

RI S2852

Accident And Sickness Insurance Policies